Funding for this research was provided by:
National Institute for Health Research (13/33/45)
Text and Data Mining valid from 2020-01-06
Received: 31 May 2019
Accepted: 22 October 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: Favourable ethical opinion for the study was confirmed by the North West, Liverpool-East National Research Ethics Committee on 1 August 2014 (REC reference number 14/NW/1016). A subsequent substantial amendment in ethical approval was obtained on 18 March 2016 pertaining to the RCT (to allow a prize draw of 10 lots of £25 for patients completing follow-up data collection at 6 months and again at 12 months (£500 total)).Research and Governance approval was also gained from the North of England Commissioning Support Unit (for Newcastle and Gateshead) and the Clinical Research Network Greater Manchester (for Salford). These were granted in October 2014 and March 2015 respectively, prior to any recruitment taking place.All participants in the study (whether dental staff or patients) received a written information sheet relating to their aspect of the study, and a written, and signed consent obtained before their involvement in the study.
: Not applicable.
: CV reports a grant from GlaxoSmithKline during the conduct of the study. GB reports a grant from GlaxoSmithKline during the conduct of the study. All other authors have nothing to declare.